November 6, 2024 – AI Proteins, a young biotech company focused on therapeutic miniprotein design employing computational methods, has secured a spot among the 25 winners of the global Falling Walls Venture Science Start-Up Competition. The startup makes use of artificial intelligence to advance new therapeutic proteins and will be headed to the Falling Walls Science Summit taking place in Berlin from November 7 to November 9, 2024, where it will be sharing the stage with multiple investors, entrepreneurs, and policymakers around the world.
Dr. Chris Bahl, AI Proteins’ Founder and Chief Scientific Officer, stated, “We are honored to be recognized at Falling Walls. “This recognition is a testament to the hard work and dedication of our team. We are excited to showcase our technology on the world stage and continue to drive innovation in protein-based therapeutics.”
The company’s approach combines artificial intelligence-based protein design with high-throughput drug discovery to create robust and targeted proteins constructed for oncology as well as other therapy areas, with collaborations in inflammatory and metabolic diseases.
Launched in 2009, the Falling Walls Science Summit has become one of the most recognized international arenas to foster productive and eco-friendly interdisciplinary scientific innovations that have effects on society.
Latest Stories:
Samsung Unveils AI-Powered Galaxy Book5 Pro 360 with Intel Ultra Processors
Sand Technologies Joins Envision Racing to Advance AI Solutions in Formula E
Wipro and RELEX Solutions Join Forces for AI-Powered Supply Chain Optimization
What is your reaction?
